The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis.

ABSTRACT:

Background

Within China, Hepatitis B virus (HBV) infection remains widely prevalent and one of the major public health problems. There have been only two previous estimates of its prevalence at the population level in China, with the latest survey conducted in 2006. A meta-analysis estimated the prevalence of HBV within China between 2013 and 2017 as 7%. This review provides an updated estimate of HBV prevalence in China from 2018 to 2022.

Methods

Systematic searches of literature from January 1, 2018 to December 25, 2022 were conducted in four international databases (Medline, Web of Science, Embase, Cochrane Database of Systematic Reviews) and three Chinese databases (CNKI, CBM, and WanFang data). Random-effects meta-analyses were conducted to calculate the pooled HBV prev

SUBMITTER: Bai S 

PROVIDER: S-EPMC10870619 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature